SCHEMBL27085239

SCHEMBL27085239

CC1OC(Oc2ccc3c(CCN(C)C)c[nH]c3c2)C(O)C(O)C1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 4/20 0.58
▸ HTR2A P28223 6/20 0.51
▸ HTR2C P28335 6/20 0.51
▸ HTR2B P41595 5/20 0.51
▸ HTR1D P28221 9/20 0.46
▸ HTR1B P28222 7/20 0.46
▸ HTR1A P08908 7/20 0.46
▸ HTR3E A5X5Y0 3/20 0.46
▸ HTR3B O95264 3/20 0.46
▸ HTR1E P28566 3/20 0.46
▸ HTR1F P30939 3/20 0.46
▸ HTR7 P34969 3/20 0.46
▸ HTR3A P46098 3/20 0.46
▸ HTR5A P47898 3/20 0.46
▸ HTR4 Q13639 3/20 0.46
▸ HTR3D Q70Z44 3/20 0.46
▸ HTR3C Q8WXA8 3/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27085194 0.92 HTR1D (0.58) HTR6HTR2AHTR2CHTR2BHTR1D
SCHEMBL27085096 0.91 HTR6 (0.47) HTR6HTR2AHTR2CHTR2BHTR1D
SCHEMBL27084888 0.90 HTR6 (0.46) HTR6HTR2AHTR2CHTR2BHTR1D
SCHEMBL27084710 0.90 HTR1A (0.53) HTR6HTR2AHTR2CHTR2BHTR1D
SCHEMBL27084913 0.89 HTR6 (0.45) HTR6HTR2AHTR2CHTR2BHTR1D
SCHEMBL27085191 0.89 HTR6 (0.44) HTR6HTR2AHTR2CHTR2BHTR1D
SCHEMBL27084722 0.89 HTR1D (0.46) HTR6HTR2AHTR2CHTR2BHTR1D
SCHEMBL27085143 0.88 HTR6 (0.56) HTR6HTR2AHTR2CHTR2BCA12
SCHEMBL27085234 0.88 HTR6 (0.43) HTR6HTR2AHTR2CHTR2BHTR1D
SCHEMBL27084696 0.87 HTR6 (0.43) HTR6HTR2AHTR2CHTR2BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043382-A1 MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES COMPASS PATHFINDER LIMITED (GB) 2024-02-08 — — US disclosed
CN-117120415-A Modified indole alkaloids for therapeutic use 指南针探路者有限公司 2023-11-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043382-A1 MODIFIED INDOLE ALKALOIDS FOR THERAPEUTIC USES INMT, AANAT, HNMT HTR6 57/4885HTR2A 53/4885HTR2C 482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback